Not all TRD treatments are pharmacological. Neuromodulation techniques — including transcranial magnetic stimulation (TMS), electroconvulsive therapy (ECT), and emerging approaches — offer alternatives for patients who do not respond to medication. These technologies are a significant and growing segment of the treatment resistant depression market.
TMS uses magnetic fields to stimulate brain regions involved in mood regulation, offering a non-invasive option with minimal side effects. ECT remains highly effective for severe depression despite its historical stigma. According to treatment resistant depression market research, neuromodulation is expanding as technology improves and access increases.
Innovation includes accelerated TMS protocols, deep brain stimulation research, and personalised targeting using neuroimaging.
Challenges include cost, access, and stigma.
Yet the direction is clear: neuromodulation will play a growing role in TRD care, and the market is expected to benefit as technology advances.
People Also Ask
Q: What is TMS for depression?
A: Transcranial magnetic stimulation is a non-invasive technique that uses magnetic fields to stimulate brain regions involved in mood regulation.
Q: Is ECT still used for depression?
A: Yes — ECT remains an effective treatment for severe and treatment-resistant depression.
Tags: #Neuromodulation #TMS #ECT #TRD #BrainStimulation #MarketTrends